30 Stocks Moving In Friday's Mid-Day Session

Gainers

• Yuma Energy, Inc. YUMA shares climbed 47.6% to $4.5298 amid crude oil which was up more than 3.5% to over the $63/barrel level. Traders have targeted this name previously given volatility in oil markets; the company has a float of just over 1 million shares, making it susceptible to increased volatility.
• Titan Pharmaceuticals, Inc. TTNP gained 37.2% to $0.2950.
• Camber Energy, Inc. CEI shares rose 28.7% to $2.1880 after falling 10.99% on Thursday.
• BioXcel Therapeutics, Inc. BTAI gained 28.3% to $17.45.
• Acorda Therapeutics, Inc. ACOR shares rose 20.4% to $2.3591 after Point72 reported a 9.8% passive stake in the company.
• Can-Fite BioPharma Ltd. CANF gained 16.7% to $3.64 after the company announced pre-clinical data from the Hadassah Medical Center lab demonstrate that Namodenoson induces weight loss.
• Cinedigm Corp CIDM shares rose 15.7% to $0.8330 after the company signed a definitive stock purchase agreement to acquire a 29% stake in Starrise Media.
• Whiting Petroleum Corporation WLL shares rose 12.1% to $8.05.
• Valaris plc VAL surged 12.1% to $7.49. Fearnleys upgraded Valaris from Hold to Buy.
• DURECT Corporation DRRX gained 12% to $2.93.
• Nymox Pharmaceutical Corporation NYMX shares rose 11.6% to $2.60.
• Yunji Inc. YJ surged 11.6% to $5.00.
• W&T Offshore, Inc. WTI rose 11% to $5.97 after the U.S. confirmed an airstrike that killed a top Iranian commander. The death of Soleimani has raised geopolitical concerns in the Middle East, causing oil prices to rise.
• Ocular Therapeutix, Inc. OCUL gained 10.8% to $4.3750.
• Extraction Oil & Gas, Inc. XOG rose 9.7% to $2.3150.
• Whiting Petroleum Corporation WLL shares jumped 9.6% to $7.87.
• Lamb Weston Holdings, Inc. LW gained 9.5% to $92.14 after the company reported better-than-expected Q2 results and raised FY20 adjusted EBITDA guidance.
• Chembio Diagnostics, Inc. CEMI surged 9.4% to $4.99. Chembio Diagnostics said it anticipates FDA approval for its DPP HIV-Syphilis System, which includes the DPP HIV-Syphilis test and DPP Micro Reader, during the first quarter of 2020. The company added its clinical study demonstrated that the system met the performance requirements established with the FDA.
• Oasis Petroleum Inc. OAS rose 8.1% to $3.47.
• NantKwest, Inc. NK gained 8% to $4.2736.

Check out these big penny stock gainers and losers

Losers

• Novan, Inc. NOVN shares dipped 72.4% to $0.8589. Novan released top-line efficacy results from the Phase 3 B-SIMPLE program that evaluated SB206 for the treatment of molluscum contagiosum, which showed that statistical significance was not achieved for the primary endpoint in either B-SIMPLE1 or B-SIMPLE2.
• DPW Holdings, Inc. DPW fell 31.2% to $1.65 after rising 101.65% on Thursday.
• Synthesis Energy Systems, Inc. SES fell 14.6% to $9.74 after rising 100.00% on Thursday.
• Landec Corporation LNDC shares fell 11.4% to $9.90 after the company reported a wider-than-expected loss for its second quarter.
• Mereo BioPharma Group plc MREO dropped 10.3% to $2.88.
• Incyte Corporation INCY fell 10% to $77.38 after the company disclosed that Itacitinib did not statistically improve overall response rate or non-relapse mortality compared to placebo in Phase 3 study.
• Viveve Medical, Inc. VIVE dropped 9.2% to $0.9989 in sympathy with the overall market after a U.S. airstrike killed Iranian Major-General Qasem Soleimani.
• Anavex Life Sciences Corp. AVXL dipped 8.7% to $2.62.
• Recon Technology, Ltd. RCON dropped 8.5% to $2.6343.
• Abeona Therapeutics Inc. ABEO shares fell 8.1% to $2.95.